The work describes an integrated optical platform for recognition of Cr 3+ at the picomolar level (0.66 pM). The condensation of a fluorene unit with l -leucine led to the development of a highly fluorescent molecular probe L which detects Cu 2+ following a turn-off signaling mechanism. Further, the L-Cu 2+ ensemble has been successfully utilized as a light-up signaling tool for selective turn-on sensing of Cr 3+, for the first time, at the picomolar level through quencher displacement. This sensing process eventually detects selectively one paramagnetic cation through turn-on signaling by the displacement of another paramagnetic cation. We have successfully shown that the common sensitivity issues associated with displacement approaches can be overcome by suitable ligand design. The present integrated system, L-Cu 2+, has been found to be sensitive enough to detect Cr 3+ at the picomolar level even in real samples, including water from different sources such as tap water, river water, and drinking water.
No takes yet. Share an insight, caveat, or question.
Dey et al. (2016) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: